BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

3-V Biosciences 

1050 Hamilton Court

Menlo Park  California  94025  U.S.A.
Phone: 650-561-8600 Fax: N/A


SEARCH JOBS





Segment
Pharmaceuticals





 Company News
3-V Biosciences Commences Patient Dosing In Phase 1 Clinical Study Of FASN Inhibitor TVB-2640 In Patients With Advanced Solid Tumors 12/4/2013 10:59:24 AM    More...
3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the American Association for Cancer Research-National Cancer Institute-EORTC International Conference on Molecular Targets and Cancer Therapeutics 10/21/2013 2:29:21 PM    More...
3-V Biosciences Nabs $20 Million Series C 6/21/2013 7:06:02 AM    More...
3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for Study of Liver Diseases Annual Meeting 2012 11/12/2012 10:15:53 AM    More...
3-V Biosciences to Present Data on HCV Product Candidates at the American Association for Study of Liver Diseases Annual Meeting 2012 10/1/2012 11:09:11 AM    More...
3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference 7/10/2012 9:50:37 AM    More...
3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology 6/29/2012 10:39:00 AM    More...
3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer 8/15/2011 11:31:16 AM    More...
3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer 2/10/2011 7:24:03 AM    More...
3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer 9/30/2010 8:03:09 AM    More...
12